GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Akums Drugs and Pharmaceuticals Ltd

Akums Drugs and Pharmaceuticals: Sunil Jaiswal Resigns from Senior Management

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 31 Oct 2026, 06:36 PM IST  ·  BSE ID: 983659fb-0b52-4c78-ad13-69da6255f0c6
View Original BSE Filing (PDF)
💡
In Simple Terms
A key executive, Sunil Jaiswal, has left Akums Drugs and Pharmaceuticals due to personal reasons and age.
🤖 AI Summary
  • Mr. Sunil Jaiswal, SVP R&D, resigned from Senior Management.
  • Cessation effective October 31, 2026, due to family commitments.
  • Mr. Jaiswal has attained the age of 61 years.
  • Resignation submitted August 5, 2026, agreed relieving October 31, 2026.
🏢 How This Affects the Company
⚙️
Operational Impact
The departure of the Senior Vice President – Research & Development may necessitate a restructuring of the R&D leadership and team.
⚠️
Risk Impact
The exit of a senior management member, particularly in R&D, can introduce uncertainty regarding ongoing projects and future innovation pipeline.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this management change.
👤
Who Is Affected
Shareholders holding shares in Akums Drugs and Pharmaceuticals are indirectly affected by changes in senior management.
🔍
Management Signal
The company is adhering to disclosure norms for senior management changes as per SEBI regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of new SVP R&D appointment.
Updates on R&D project continuity and pipeline.
Subsequent board meeting minutes for any related decisions.
LOW RISK Standard management resignation, not indicating systemic issues.
💡 Investor Takeaway
Akums Drugs and Pharmaceuticals' Senior VP of R&D, Mr. Sunil Jaiswal, has resigned due to family commitments and age. His last day was October 31, 2026.
❓ Frequently Asked Questions
Who resigned from Akums Drugs and Pharmaceuticals?
Mr. Sunil Jaiswal, Senior Vice President – Research & Development, resigned from Akums Drugs and Pharmaceuticals.
When was Mr. Sunil Jaiswal's last day at Akums Drugs and Pharmaceuticals?
Mr. Sunil Jaiswal's last day at Akums Drugs and Pharmaceuticals was October 31, 2026.
Why did Mr. Sunil Jaiswal resign?
Mr. Sunil Jaiswal resigned due to family commitments and having attained the age of 61 years.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.